ID   STXA_SHIDY              Reviewed;         315 AA.
AC   Q9FBI2;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   03-AUG-2022, entry version 79.
DE   RecName: Full=Shiga toxin subunit A;
DE            EC=3.2.2.22;
DE   Flags: Precursor;
GN   Name=stxA;
OS   Shigella dysenteriae.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Shigella.
OX   NCBI_TaxID=622;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Kozlov Y.V., Kabishev A.A., Fedchenko V.I., Bayev A.A.;
RT   "Cloning and primary structure of Shigella toxin genes.";
RL   Dokl. Biochem. 295:744-749(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2830229; DOI=10.1128/jb.170.3.1116-1122.1988;
RA   Strockbine N.A., Jackson M.P., Sung L.M., Holmes R.K., O'Brien A.D.;
RT   "Cloning and sequencing of the genes for Shiga toxin from Shigella
RT   dysenteriae type 1.";
RL   J. Bacteriol. 170:1116-1122(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3049254; DOI=10.1016/0378-1119(88)90398-8;
RA   Kozlov Y.V., Kabishev A.A., Lukyanov E.V., Bayev A.A.;
RT   "The primary structure of the operons coding for Shigella dysenteriae toxin
RT   and temperature phage H30 shiga-like toxin.";
RL   Gene 67:213-221(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=H2765-39/81 / Type 1;
RX   PubMed=10948097; DOI=10.1128/iai.68.9.4856-4864.2000;
RA   Unkmeir A., Schmidt H.;
RT   "Structural analysis of phage-borne stx genes and their flanking sequences
RT   in shiga toxin-producing Escherichia coli and Shigella dysenteriae type 1
RT   strains.";
RL   Infect. Immun. 68:4856-4864(2000).
RN   [5]
RP   EFFECT ON EUKARYOTIC RIBOSOME.
RX   PubMed=3276522; DOI=10.1111/j.1432-1033.1988.tb13756.x;
RA   Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K.;
RT   "Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of
RT   Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the
RT   toxins.";
RL   Eur. J. Biochem. 171:45-50(1988).
RN   [6]
RP   CLEAVAGE BY FURIN.
RX   PubMed=7738018; DOI=10.1074/jbc.270.18.10817;
RA   Garred O., van Deurs B., Sandvig K.;
RT   "Furin-induced cleavage and activation of Shiga toxin.";
RL   J. Biol. Chem. 270:10817-10821(1995).
RN   [7]
RP   MUTAGENESIS OF TRP-299; ASP-300; ARG-310 AND ARG-311.
RX   PubMed=7768810; DOI=10.1128/jb.177.11.3128-3132.1995;
RA   Jemal C., Haddad J.E., Begum D., Jackson M.P.;
RT   "Analysis of Shiga toxin subunit association by using hybrid A polypeptides
RT   and site-specific mutagenesis.";
RL   J. Bacteriol. 177:3128-3132(1995).
RN   [8]
RP   MUTAGENESIS OF PHE-248; ALA-253; ILE-254; LEU-255 AND GLY-256.
RX   PubMed=9784530; DOI=10.1128/iai.66.11.5252-5259.1998;
RA   Suhan M.L., Hovde C.J.;
RT   "Disruption of an internal membrane-spanning region in Shiga toxin 1
RT   reduces cytotoxicity.";
RL   Infect. Immun. 66:5252-5259(1998).
RN   [9]
RP   CRYSTALLIZATION.
RX   PubMed=8345529; DOI=10.1006/jmbi.1993.1421;
RA   Kozlov Y.V., Chernaia M.M., Fraser M.E., James M.N.G.;
RT   "Purification and crystallization of Shiga toxin from Shigella
RT   dysenteriae.";
RL   J. Mol. Biol. 232:704-706(1993).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 23-315.
RX   PubMed=7656009; DOI=10.1038/nsb0194-59;
RA   Fraser M.E., Chernaia M.M., Kozlov Y.V., James M.N.G.;
RT   "Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A
RT   resolution.";
RL   Nat. Struct. Biol. 1:59-64(1994).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 23-315.
RX   PubMed=15075327; DOI=10.1074/jbc.m401939200;
RA   Fraser M.E., Fujinaga M., Cherney M.M., Melton-Celsa A.R., Twiddy E.M.,
RA   O'Brien A.D., James M.N.G.;
RT   "Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7.";
RL   J. Biol. Chem. 279:27511-27517(2004).
CC   -!- FUNCTION: The A subunit is responsible for inhibiting protein synthesis
CC       through the catalytic inactivation of 60S ribosomal subunits. After
CC       endocytosis, the A subunit is cleaved by furin in two fragments, A1 and
CC       A2: A1 is the catalytically active fragment, and A2 is essential for
CC       holotoxin assembly with the B subunits.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endohydrolysis of the N-glycosidic bond at one specific
CC         adenosine on the 28S rRNA.; EC=3.2.2.22;
CC   -!- SUBUNIT: Shiga toxin contains a single subunit A and five copies of
CC       subunit B.
CC   -!- SIMILARITY: Belongs to the ribosome-inactivating protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X07903; CAA30741.1; -; Genomic_DNA.
DR   EMBL; M19437; AAA98347.1; -; Genomic_DNA.
DR   EMBL; M24352; AAA26538.1; -; Genomic_DNA.
DR   EMBL; AJ271153; CAC05622.1; -; Genomic_DNA.
DR   RefSeq; WP_000691354.1; NZ_UAUQ01000013.1.
DR   PDB; 1DM0; X-ray; 2.50 A; A/L=23-309.
DR   PDB; 1R4Q; X-ray; 2.50 A; A/L=23-315.
DR   PDBsum; 1DM0; -.
DR   PDBsum; 1R4Q; -.
DR   AlphaFoldDB; Q9FBI2; -.
DR   SMR; Q9FBI2; -.
DR   BindingDB; Q9FBI2; -.
DR   ChEMBL; CHEMBL3879822; -.
DR   UniLectin; Q9FBI2; -.
DR   BioCyc; MetaCyc:MON-18743; -.
DR   EvolutionaryTrace; Q9FBI2; -.
DR   GO; GO:0030598; F:rRNA N-glycosylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0017148; P:negative regulation of translation; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.420.10; -; 1.
DR   Gene3D; 4.10.470.10; -; 1.
DR   InterPro; IPR036041; Ribosome-inact_prot_sf.
DR   InterPro; IPR001574; Ribosome_inactivat_prot.
DR   InterPro; IPR017988; Ribosome_inactivat_prot_CS.
DR   InterPro; IPR016138; Ribosome_inactivat_prot_sub1.
DR   InterPro; IPR016139; Ribosome_inactivat_prot_sub2.
DR   InterPro; IPR016331; Shiga-like_toxin_subunit_A.
DR   Pfam; PF00161; RIP; 1.
DR   PIRSF; PIRSF001924; Shigella_toxin_subunit_A; 1.
DR   SUPFAM; SSF56371; SSF56371; 1.
DR   PROSITE; PS00275; SHIGA_RICIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Hydrolase; Protein synthesis inhibitor;
KW   Signal; Toxin; Virulence.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..315
FT                   /note="Shiga toxin subunit A"
FT                   /id="PRO_0000312302"
FT   REGION          23..273
FT                   /note="A1"
FT   REGION          274..315
FT                   /note="A2"
FT   ACT_SITE        189
FT   SITE            273..274
FT                   /note="Cleavage; by furin"
FT   DISULFID        264..283
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         248
FT                   /note="F->Y: No effect on enzymatic activity; 10-fold
FT                   decrease in cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         253
FT                   /note="A->D: 225-fold decrease in cytotoxicity, probably
FT                   due to reduced translocation across the ER membrane; when
FT                   associated with E-256."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         253
FT                   /note="A->D: No effect on enzymatic activity; slight
FT                   decrease in cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         254
FT                   /note="I->E: No effect on enzymatic activity or
FT                   cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         255
FT                   /note="L->E: No effect on enzymatic activity or
FT                   cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         256
FT                   /note="G->E: 225-fold decrease in cytotoxicity, probably
FT                   due to reduced translocation across the ER membrane; when
FT                   associated with D-253."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         256
FT                   /note="G->E: No effect on enzymatic activity; slight
FT                   decrease in cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:9784530"
FT   MUTAGEN         299
FT                   /note="W->F,G: No effect on cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:7768810"
FT   MUTAGEN         300
FT                   /note="D->K: Reduced subunit association and cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:7768810"
FT   MUTAGEN         310
FT                   /note="R->E: Reduced subunit association and cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:7768810"
FT   MUTAGEN         311
FT                   /note="R->E: Reduced subunit association and cytotoxicity."
FT                   /evidence="ECO:0000269|PubMed:7768810"
FT   CONFLICT        190
FT                   /note="A -> P (in Ref. 2; CAA30741)"
FT                   /evidence="ECO:0000305"
FT   STRAND          24..28
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           32..46
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          47..55
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          58..63
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          71..77
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   TURN            81..83
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          90..94
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   TURN            95..98
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          99..104
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   TURN            106..108
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          110..113
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           115..117
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          126..129
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           136..143
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           154..165
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          169..171
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           174..192
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           194..201
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           216..222
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           225..231
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           232..234
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          239..243
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          246..250
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           251..257
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   TURN            286..288
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          291..293
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   STRAND          295..300
FT                   /evidence="ECO:0007829|PDB:1DM0"
FT   HELIX           301..307
FT                   /evidence="ECO:0007829|PDB:1DM0"
SQ   SEQUENCE   315 AA;  34814 MW;  8A423DF7ABF58F30 CRC64;
     MKIIIFRVLT FFFVIFSVNV VAKEFTLDFS TAKTYVDSLN VIRSAIGTPL QTISSGGTSL
     LMIDSGTGDN LFAVDVRGID PEEGRFNNLR LIVERNNLYV TGFVNRTNNV FYRFADFSHV
     TFPGTTAVTL SGDSSYTTLQ RVAGISRTGM QINRHSLTTS YLDLMSHSGT SLTQSVARAM
     LRFVTVTAEA LRFRQIQRGF RTTLDDLSGR SYVMTAEDVD LTLNWGRLSS VLPDYHGQDS
     VRVGRISFGS INAILGSVAL ILNCHHHASR VARMASDEFP SMCPADGRVR GITHNKILWD
     SSTLGAILMR RTISS
//
